Fei Shen

The publications attributed to this name span cancer medicine (particularly prostate and breast cancer research and clinical trials) as well as unrelated engineering and computer-vision topics, suggesting the record may combine multiple authors sharing the same name. Within the medical work, the focus includes identifying molecular targets and biomarkers in prostate cancer and evaluating cancer treatment outcomes in clinical studies.

Publication activity was low and intermittent through the early years of the decade before rising sharply in 2025, though this spike partly reflects many supplementary-figure entries from a single study.

Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026

Typically publishes in teams of ~11 · 3% small-team papers (≤3 authors) · across 17 venues